Effect of Large Volume Paracentesis on Fatigue in Cirrhosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by Weill Medical College of Cornell University.
Recruitment status was  Recruiting
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
First received: January 15, 2008
Last updated: November 4, 2010
Last verified: November 2010
The purposeof this study is to determine the effect of a large volume paracentesis (procedure in whihc a catheter is placed to remove fluid from the abdomen) on the severity of fatigue i patients with cirrhosis (severe scarring of the liver) and large volume ascites (fluid in the abdomen).


Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Effect of Large Volume Paracentesis on Fatigue in Cirrhosis

Resource links provided by NLM:

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • Improvement in Fatigue symptomatology, as defined by fatigue questionnairre [ Time Frame: instantly ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Improvement in sleep [ Time Frame: post paracentesis ] [ Designated as safety issue: No ]

Estimated Enrollment: 10
Study Start Date: January 2008
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Group 1
Patients with cirrhosis, who have refractory ascites requiring large volume paracentesis


Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with cirrhosis and refractory ascites.

Inclusion Criteria:

  • ambulatory patient with cirrhosis
  • baseline Cr <2
  • ability to complete psychometric testing
  • refractory ascites

Exclusion Criteria:

  • Cr >2
  • history of Gastrointestinal bleed
  • history of infection
  • history of renal failure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00603200

Contact: Samual Sigal, MD 6469625483
Contact: Reem Sharaiha, MD 212-305-2323 rzs2110@columbia.edu

United States, New York
New York Presbyterial, Weill Cornell medical College Recruiting
New York, New York, United States, 10021
Contact: Samual Sigal, Md    646-962-5483      
Contact: Reem Sharaiha, MD    12127465020      
Principal Investigator: Samual Sigal, MD         
Sub-Investigator: Reem Sharaiha, MD         
Sponsors and Collaborators
Weill Medical College of Cornell University
Principal Investigator: Samual Sigal, MD Weill Medical College of Cornell University
Study Director: Reem Sharaiha, MD New York Hospital-Cornell/Columbia
  More Information

Responsible Party: Dr Samual Sigal, Department of Gastroentorology and Hepatology.
ClinicalTrials.gov Identifier: NCT00603200     History of Changes
Other Study ID Numbers: 0701008974 
Study First Received: January 15, 2008
Last Updated: November 4, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:
Quality of Life

Additional relevant MeSH terms:
Liver Cirrhosis
Digestive System Diseases
Liver Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 30, 2016